Supernus, Inc. (SUPN) stock
SUPNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$28.96−0.08 (-0.28%)
Close on Nov 18, 2026Market cap $3.42BP/E 8.1Yield –
Supernus shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Supernus's shares outstanding was 122M at Sep 30, 2026. For fiscal 2025 it was 128M, down 3.8% from the year before. The highest annual figure on record is 152M in fiscal 2021.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 128M | -3.8% |
| FY2024 | Dec 31, 2024 | 133M | -2.9% |
| FY2023 | Dec 31, 2023 | 137M | -1.4% |
| FY2022 | Dec 31, 2022 | 139M | -8.5% |
| FY2021 | Dec 31, 2021 | 152M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 122M | -5.4% |
| Q2 FY2026 | Jun 30, 2026 | 124M | -1.6% |
| Q1 FY2026 | Mar 31, 2026 | 129M | +3.2% |
| Q4 FY2025 | Dec 31, 2025 | 131M | +0.8% |
| Q3 FY2025 | Sep 30, 2025 | 129M | -3.0% |
| Q2 FY2025 | Jun 30, 2025 | 126M | -6.7% |
| Q1 FY2025 | Mar 31, 2025 | 125M | -8.8% |
| Q4 FY2024 | Dec 31, 2024 | 130M | – |
| Q3 FY2024 | Sep 30, 2024 | 133M | – |
| Q2 FY2024 | Jun 30, 2024 | 135M | – |
| Q1 FY2024 | Mar 31, 2024 | 137M | – |
See a number that looks wrong?